REGULATION OF IL-2 RECEPTOR BY THE CD4 LIGAND IL-16
CD4 配体 IL-16 对 IL-2 受体的调节
基本信息
- 批准号:6348838
- 负责人:
- 金额:$ 11.07万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2000
- 资助国家:美国
- 起止时间:2000-09-15 至 2003-07-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
IL-16 was identified, characterized and cloned in the laboratory of Dr. Parada's co-sponsors, Drs. Center and Cruikshank. One of the functions of IL-16 is a selective activation
for CD4+ T cells. Other major functions include chemotactic activity for all
CD4+ leukocytes, a competence growth factor for CD4+ T cells, inhibition of
the mixed lymphocyte reaction and TcR activation, and inhibition of HIV-1
replication. All of IL-16`s functions require Cdr which it utilizes as part of
its membrane recognition unit. Suggesting that CD4 has functions other than as
the recognized intercellular adhesion molecule complementary to MHC II
molecules during antigen presentation. These other functions of CD4, namely as
a chemotactic and growth factor receptor are mediated by interaction with its
natural lymphokine ligand, IL-16. Dr. Parada's studies with IL-16 demonstrate
that signaling through CD4 can take place independent of the TcR and CD3 and
result in cell migration and cell cycle progression to an IL-2R, IL-2R, G1
competence point. Recent studies in their laboratory have shown that long term
treatment (over four weeks) with a combination of IL-16 and IL-2 leads to a
dramatic synergistic increase in CD4 cells expressing IL-2R.
This proposal will explore the relationship between IL-16 induced CD4-
dependent activation of transcription factors associated with IL-2R and IL-2R
expression. Experiments described below will be performed to identify IL-16-
responsive elements within the IL-2R and gene expression. This will allow Dr.
Parada to learn and apply molecular biology techniques while allowing her to
establish herself as an IL-16 expert with an independent project that is a
logical extension of her scientific goals.
IL-16是在Parada博士的共同赞助者Drs. Center和Cruikshank的实验室中鉴定、表征和克隆的。IL-16的功能之一是选择性激活
CD 4 + T细胞。其他主要功能包括所有人的趋化活性
CD 4+白细胞,CD 4 + T细胞的感受态生长因子,
混合淋巴细胞反应和TcR活化,以及HIV-1抑制
复制的IL-16的所有功能都需要Cdr,它利用Cdr作为
其膜识别单元。这表明CD 4除了作为
公认的与MHC II互补的细胞间粘附分子
抗原呈递过程中的分子。CD 4的其他功能,即
趋化因子和生长因子受体通过与其
天然淋巴因子配体IL-16。Parada博士对IL-16的研究表明,
通过CD 4的信号传导可以独立于TcR和CD 3发生,
导致细胞迁移和细胞周期进展为IL-2 R、IL-2 R、G1
能力点。他们实验室最近的研究表明,
用IL-16和IL-2的组合治疗(超过四周)导致
表达IL-2 R的CD 4细胞的显著协同增加。
本研究旨在探讨IL-16诱导的CD 4-
与IL-2 R相关的转录因子的依赖性活化和IL-2 R
表情将进行下文所述的实验以鉴定IL-16。
IL-2 R和基因表达中的应答元件。这将使博士。
Parada学习和应用分子生物学技术,同时允许她
将自己定位为IL-16专家,并开展独立项目,
科学目标的逻辑延伸。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
NEREIDA A PARADA其他文献
NEREIDA A PARADA的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('NEREIDA A PARADA', 18)}}的其他基金
REGULATION OF IL-2 RECEPTOR BY THE CD4 LIGAND IL-16
CD4 配体 IL-16 对 IL-2 受体的调节
- 批准号:
6532868 - 财政年份:2000
- 资助金额:
$ 11.07万 - 项目类别:
REGULATION OF IL-2 RECEPTOR BY THE CD4 LIGAND IL-16
CD4 配体 IL-16 对 IL-2 受体的调节
- 批准号:
6374729 - 财政年份:2000
- 资助金额:
$ 11.07万 - 项目类别:
相似海外基金
CAREER: Elucidating spatial and epigenetic regulation of gene expression during human development using photopatterning and single-cell multiomics
职业:利用光模式和单细胞多组学阐明人类发育过程中基因表达的空间和表观遗传调控
- 批准号:
2339849 - 财政年份:2024
- 资助金额:
$ 11.07万 - 项目类别:
Continuing Grant
CAREER: Scalable algorithms for regularized and non-linear genetic models of gene expression
职业:基因表达的正则化和非线性遗传模型的可扩展算法
- 批准号:
2336469 - 财政年份:2024
- 资助金额:
$ 11.07万 - 项目类别:
Continuing Grant
CAREER: Epigenetic Regulation of Gene Expression in Engineered Prokaryotes
职业:工程原核生物基因表达的表观遗传调控
- 批准号:
2338573 - 财政年份:2024
- 资助金额:
$ 11.07万 - 项目类别:
Continuing Grant
MFB: RNA modifications of frameshifting stimulators: cellular platforms to engineer gene expression by computational mutation predictions and functional experiments
MFB:移码刺激器的RNA修饰:通过计算突变预测和功能实验来设计基因表达的细胞平台
- 批准号:
2330628 - 财政年份:2024
- 资助金额:
$ 11.07万 - 项目类别:
Standard Grant
22-BBSRC/NSF-BIO Building synthetic regulatory units to understand the complexity of mammalian gene expression
22-BBSRC/NSF-BIO 构建合成调控单元以了解哺乳动物基因表达的复杂性
- 批准号:
BB/Y008898/1 - 财政年份:2024
- 资助金额:
$ 11.07万 - 项目类别:
Research Grant
How does the chromatin remodeller CHD4 regulate gene expression?
染色质重塑因子 CHD4 如何调节基因表达?
- 批准号:
DP240102119 - 财政年份:2024
- 资助金额:
$ 11.07万 - 项目类别:
Discovery Projects
Data-driven model links BMIz to gene expression in pediatric asthma
数据驱动模型将 BMIz 与小儿哮喘基因表达联系起来
- 批准号:
493135 - 财政年份:2023
- 资助金额:
$ 11.07万 - 项目类别:
Regulation of gene expression by the La and La-related proteins
La 和 La 相关蛋白对基因表达的调节
- 批准号:
489704 - 财政年份:2023
- 资助金额:
$ 11.07万 - 项目类别:
Operating Grants
Investigating the role of SARS-CoV-2 and MERS-CoV transcription regulatory sequence (TRS) in viral gene expression and virulence
研究 SARS-CoV-2 和 MERS-CoV 转录调控序列 (TRS) 在病毒基因表达和毒力中的作用
- 批准号:
494272 - 财政年份:2023
- 资助金额:
$ 11.07万 - 项目类别:
Operating Grants
Application for 2024 CIHR NIF (ECR): Investigating the role of SARS-CoV-2 and MERS-CoV transcription regulatory sequence (TRS) in viral gene expression and virulence
2024 CIHR NIF (ECR) 申请:研究 SARS-CoV-2 和 MERS-CoV 转录调控序列 (TRS) 在病毒基因表达和毒力中的作用
- 批准号:
491942 - 财政年份:2023
- 资助金额:
$ 11.07万 - 项目类别:














{{item.name}}会员




